Norway· NO-ID_2CF1B4E1-A1C6-46C0-9A81-72BF14015DB0
Gabbroral
A paromomycin product containing paromomycin, registered in Norway by Pfizer (3). The same ATC class is registered in 9 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Paromomycin is registered in 9 of 19 countries.
Countries holding a registration under ATC A07AA06 (paromomycin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 5 of them publish a price we can compare per daily dose
Paromomycin · ATC A07AA06
9 / 19 countries
- Belgiumprice
- Canada
- Germany
- Italyprice
- Japan
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of paromomycin costs, country by country.
Normalised to the WHO defined daily dose (3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Paromomycin · price per daily dose (3 g)
USD · FX 28 Sept 2026
- IT Italy$8.91
The record
At a glance
FEST (Norway)- Active substance
- Paromomycin
- Manufacturer
- Pfizer (3)
- Country
- Norway (NO)
- ATC code
- A07AA06
- ATC class
- Paromomycin
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_2CF1B4E1-A1C6-46C0-9A81-72BF14015DB0
- no_varenummer36482616
- gtin5415062304198
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
35 interactions on record for paromomycin.
Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Paromomycin · interactions on record
35 records
- 10 severe
- 23 moderate
- 2 minor
Most severe, free to view
- TubocurarineM03AA02severe
- SuxamethoniumM03AB01severe
- PancuroniumM03AC01severe
- VecuroniumM03AC03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Paromomycin in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomGabbroral 250mg tabletsImported (Italy)
- GermanyHumatinPfizer Pharma Gmbh
- ItalyHUMATINPFIZER ITALIA S.R.L.
- SpainHUMATIN 250 MG CAPSULAS DURASPfizer S.L.
- Japanパロモマイシン硫酸塩ファイザー
- BelgiumGabbroral 250 mgPfizer
- United StatesHumatinWaylis Therapeutics LLC
- CanadaHUMATINSEARCHLIGHT PHARMA INC
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Austria · Humatin
- Belgium · Gabbroral
- Germany · Humatin, Humatin Kapseln
- Spain · Humatin
- Italy · Humatin, Kaman
- Luxembourg · Gabbroral
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/038041c0-1063-46ca-a9be-a5fc8429700f GET /v1/drugs/038041c0-1063-46ca-a9be-a5fc8429700f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Paromomycin",
"merkevare_id": "ID_2CF1B4E1-A1C6-46C0-9A81-72BF14015DB0",
"name_form_strength": "Gabbroral tab 250 mg",
"prescription_group": "C"
}See everything about paromomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.